These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 15217960)

  • 41. Present trends in the treatment of advanced non small-cell lung cancer.
    Parvez T; Allam AR; Iskandrani A; Khan MA
    J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of adjuvant chemotherapy in NSCLC (stages I to III).
    Coleman MH; Bueno R
    Surg Oncol Clin N Am; 2011 Oct; 20(4):757-67. PubMed ID: 21986270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.
    Goffin J; Lacchetti C; Ellis PM; Ung YC; Evans WK;
    J Thorac Oncol; 2010 Feb; 5(2):260-74. PubMed ID: 20101151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. First- and second-line therapy for advanced nonsmall cell lung cancer.
    Sculier JP; Moro-Sibilot D
    Eur Respir J; 2009 Apr; 33(4):915-30. PubMed ID: 19336594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy regimens for non-small cell lung cancer.
    Loi M; Roche N; Alifano M
    Minerva Chir; 2009 Dec; 64(6):629-41. PubMed ID: 20029359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced non-small-cell lung cancer in the elderly.
    Vamvakas L; Saloustros E; Karampeazis A; Georgoulias V
    Clin Lung Cancer; 2009 May; 10(3):158-67. PubMed ID: 19443335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. First-line chemotherapy for NSCLC: an overview of relevant trials.
    Belani CP; Langer C;
    Lung Cancer; 2002 Dec; 38 Suppl 4():13-9. PubMed ID: 12480190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted (and chemotherapeutic) agents as maintenance treatment in patients with metastatic non-small-cell lung cancer: current status and future challenges.
    Pallis AG; Syrigos K
    Cancer Treat Rev; 2012 Nov; 38(7):861-7. PubMed ID: 22217701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination chemotherapy should be standard of care for lung cancer.
    Oncology (Williston Park); 2002 Jul; 16(7):962, 986. PubMed ID: 12164561
    [No Abstract]   [Full Text] [Related]  

  • 50. Molecular predictors of response to chemotherapy in non-small cell lung cancer.
    Andrews J; Yeh P; Pao W; Horn L
    Cancer J; 2011; 17(2):104-13. PubMed ID: 21427554
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chemotherapy for renal cell carcinoma.
    Hartmann JT; Bokemeyer C
    Anticancer Res; 1999; 19(2C):1541-3. PubMed ID: 10365141
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silk purse in Atlanta: a commentary on SWOG 9509, an advanced non-small cell lung cancer trial.
    Gralla RJ
    Oncologist; 1999; 4(3):188-90. PubMed ID: 10394586
    [No Abstract]   [Full Text] [Related]  

  • 53. [Chemotherapy for non-small cell lung cancer].
    Shinkai T; Saijo N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():92-8. PubMed ID: 9216193
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemotherapy for Stage IV Non-Small Cell Lung Cancer: Protocol Versus Nonprotocol? Is Noninvestigational Treatment Worthwhile? Patient Selection? Which Regimen? What's Next?
    Bonomi P
    Semin Radiat Oncol; 1996 Apr; 6(2):110-117. PubMed ID: 10717170
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Current paradigms in first-line treatment of non-small-cell lung cancer.
    Shepherd FA
    Oncology (Williston Park); 2004 Jul; 18(8 Suppl 5):13-20. PubMed ID: 15339054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lung cancer.
    Evans TL; Lynch TJ
    Oncologist; 2001; 6(5):407-14. PubMed ID: 11675518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. State-of-the-art treatment for advanced non-small-cell lung cancer.
    Sandler A
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 13):15-22. PubMed ID: 14723002
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of non-small cell lung cancer: Advanced (metastatic) disease (corrected)].
    Berghmans T;
    Rev Med Brux; 2014; 35(3):145-59. PubMed ID: 25102581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New cytotoxic agents and molecular-targeted therapies in the treatment of metastatic breast cancer.
    Awada A
    Forum (Genova); 2002; 12(1):4-15. PubMed ID: 12634907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platinum-based second-line treatment in non-small-cell lung cancer: an old new kid on the block?
    de Lima Araújo LH; Ferreira CG
    J Clin Oncol; 2010 Jan; 28(2):e24-5; author reply e26. PubMed ID: 19933903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.